Microneedle Systems for Vaccine Delivery: the story so far

References

• Organization WH. Influenza (seasonal). fact sheet no 211. 2014. [cited 2020 Jun 12]. Available from: http://www.who.int/mediacentre/factsheets/fs211/en/.
   Google Scholar
• Troeger CE, Blacker BF, Khalil IA, et al. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2019;7(1):69–89.
   PubMed Web of Science ®Google Scholar
• Apostolopoulos V. Cancer vaccines: Research and Applications. Cancers. 2019;11(8):1041.
   Google Scholar
• Griffin P, Elliott S, Krauer K, et al. Safety, acceptability and tolerability of uncoated and excipient-coated high density silicon micro-projection array patches in human subjects. Vaccine. 2017;35(48):6676–6684.
   PubMed Web of Science ®Google Scholar
• Kim E, Erdos G, Huang S, et al. Microneedle array delivered recombinant coronavirus vaccines: immunogenicity and rapid translational development. EBioMedicine. 2020;55:102743.
   PubMed Web of Science ®Google Scholar
• World Health Organization(WHO). Health topics: vaccines. WHO official website. 2020; Available from: https://www.who.int/topics/vaccines/en/. Acceessed 2020 Jun 17
   Google Scholar
• Subbaraman N. Why daily death tolls have become unusually important in understanding the coronavirus pandemic. Nature. 2020.
   Google Scholar
• Le TT, Andreadakis Z, Kumar A, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19(5):305–306.
   PubMed Web of Science ®Google Scholar
• Yamey G, Schäferhoff M, Hatchett R, et al. Ensuring global access to COVID-19 vaccines. Lancet. 2020;395(10234):1405–1406.
   PubMed Web of Science ®Google Scholar
• Waghule T, Singhvi G, Dubey SK, et al. Microneedles: A smart approach and increasing potential for transdermal drug delivery system. Biomed Pharmacother. 2019;109:1249–1258.
   PubMed Web of Science ®Google Scholar
• He X, Sun J, Zhuang J, et al. Microneedle system for transdermal drug and vaccine delivery: devices, safety, and prospects. Dose-Response. 2019;17(4):1559325819878585.
   Web of Science ®Google Scholar
• Kim Y-C, Park J-H, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev. 2012;64(14):1547–1568.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang W, Wang S. Effect of vaccine administration modality on immunogenicity and efficacy. Expert Rev Vaccines. 2015;14(11):1509–1523.
   PubMed Web of Science ®Google Scholar
• Gamazo C, Pastor Y, Larrañeta E, et al. Understanding the basis of transcutaneous vaccine delivery. Ther Deliv. 2019;10(1):63–80.
   PubMed Web of Science ®Google Scholar
• Ramirez JEV, Sharpe LA, Peppas NA. Current state and challenges in developing oral vaccines. Adv Drug Deliv Rev. 2017;114:116–131.
   PubMed Web of Science ®Google Scholar
• Mitragotri S. Immunization without needles. Nat Rev Immunol. 2005;5(12):905–916.
   PubMed Web of Science ®Google Scholar
• Kaufmann JR, Miller R, Cheyne J. Vaccine supply chains need to be better funded and strengthened, or lives will be at risk. Health Aff. 2011;30(6):1113–1121.
   PubMed Web of Science ®Google Scholar
• Songane M. Challenges for nationwide vaccine delivery in African countries. Int J Health Econ Manag. 2018;18(2):197–219.
   PubMed Web of Science ®Google Scholar
• Corrie S, Depelsenaire A, Kendall M. Introducing the Nanopatch: A skin-based, needle-free vaccine delivery system. Aust Biochem. 2012;43:17–20.
   Google Scholar
• Vassilieva EV, Kalluri H, McAllister D, et al. Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature. Drug Deliv Transl Res. 2015;5(4):360–371.
   PubMed Web of Science ®Google Scholar
• Popova O, Ibarra de Palacios P. Reaching more children with vaccines in developing countries: key challenges of innovation and delivery. Current Medical Research and Opinion. 2016;32(1):177-181.
   Google Scholar
• Arora A, Prausnitz MR, Mitragotri S. Micro-scale devices for transdermal drug delivery. Int J Pharm. 2008;364(2):227–236.
   PubMed Web of Science ®Google Scholar
• van der Maaden K, Jiskoot W, Bouwstra J. Microneedle technologies for (trans) dermal drug and vaccine delivery. J Control Release. 2012;161(2):645–655.
   PubMed Web of Science ®Google Scholar
• Subedi RK, Oh SY, Chun M-K, et al. Recent advances in transdermal drug delivery. Arch Pharm Res. 2010;33(3):339–351.
   PubMed Web of Science ®Google Scholar
• Hossain MK, Subedi RK, Chun M-K, et al. Formulation and in vitro evaluation of transdermal drug delivery system for galantamine. J Pharm Investig. 2011;41(1):1–7.
   Google Scholar
• Chun M-K, Hossain K, Choi S-H, et al. Development of cataplasmic transdermal drug delivery system containing eutectic mixture of lidocaine and prilocaine. J Pharm Investig. 2012;42(3):139–146.
   Google Scholar
• Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26(11):1261–1268.
   PubMed Web of Science ®Google Scholar
• Ma G, Wu C. Microneedle, bio-microneedle and bio-inspired microneedle: A review. J Control Release. 2017;251:11–23.
   PubMed Web of Science ®Google Scholar
• Haj-Ahmad R, Khan H, Arshad MS, et al. Microneedle coating techniques for transdermal drug delivery. Pharmaceutics. 2015;7(4):486–502.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yu J, Kahkoska AR, et al. Advances in transdermal insulin delivery. Adv Drug Deliv Rev. 2019;139:51–70.
   PubMed Web of Science ®Google Scholar
• Bediz B, Korkmaz E, Khilwani R, et al. Dissolvable microneedle arrays for intradermal delivery of biologics: fabrication and application. Pharm Res. 2014;31(1):117–135.
   PubMed Web of Science ®Google Scholar
• Nayak A, Babla H, Han T, et al. Lidocaine carboxymethylcellulose with gelatine co-polymer hydrogel delivery by combined microneedle and ultrasound. Drug Deliv. 2016;23(2):658–669.
   PubMed Web of Science ®Google Scholar
• Alkilani AZ, McCrudden MT, Donnelly RF. Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics. 2015;7(4):438–470.
   PubMed Web of Science ®Google Scholar
• Lee KJ, Jeong SS, Roh DH, et al. A practical guide to the development of microneedle systems–In clinical trials or on the market. Int J Pharm. 2020;573:118778.
   PubMed Web of Science ®Google Scholar
• Rodgers AM, Cordeiro AS, Kissenpfennig A, et al. Microneedle arrays for vaccine delivery: the possibilities, challenges and use of nanoparticles as a combinatorial approach for enhanced vaccine immunogenicity. Expert Opin Drug Deliv. 2018;15(9):851–867.
   PubMed Web of Science ®Google Scholar
• Larraneta E, Lutton RE, Woolfson AD, et al. Microneedle arrays as transdermal and intradermal drug delivery systems: materials science, manufacture and commercial development. Mater Sci Eng R Rep. 2016;104:1–32.
   Web of Science ®Google Scholar
• Donnelly RF, Singh TRR, Woolfson AD. Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv. 2010;17(4):187–207.
   PubMed Web of Science ®Google Scholar
• Marshall S, Sahm LJ, Moore AC. The success of microneedle-mediated vaccine delivery into skin. Human Vaccines Immunother. 2016;12(11):2975–2983.
   PubMed Web of Science ®Google Scholar
• Li J, Zeng M, Shan H, et al. Microneedle patches as drug and vaccine delivery platform. Curr Med Chem. 2017;24(22):2413–2422.
   PubMed Web of Science ®Google Scholar
• Suh H, Shin J, Kim Y-C. Microneedle patches for vaccine delivery. Clin Exp Vaccine Res. 2014;3(1):42–49.
   PubMedGoogle Scholar
• Huzaira M, Rius F, Rajadhyaksha M, et al. Topographic variations in normal skin, as viewed by in vivo reflectance confocal microscopy. J Investig Dermatol. 2001;116(6):846–852.
   PubMed Web of Science ®Google Scholar
• Chaplin DD. Overview of the immune response. J Allerg Clin Immunol. 2010;125(2):S3–S23.
   PubMed Web of Science ®Google Scholar
• Villena J, Medina M, Racedo S, et al. Resistance of young mice to pneumococcal infection can be improved by oral vaccination with recombinant Lactococcus lactis. J Microbiol Immunol Infect. 2010;43(1):1–10.
   PubMedGoogle Scholar
• Arulanandam BP, Lynch JM, Briles DE, et al. Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection. Infect Immun. 2001;69(11):6718–6724.
   PubMed Web of Science ®Google Scholar
• Song J-H, Nguyen HH, Cuburu N, et al. Sublingual vaccination with influenza virus protects mice against lethal viral infection. Proc Natl Acad Sci. 2008;105(5):1644–1649.
   PubMed Web of Science ®Google Scholar
• Rouphael NG, Paine M, Mosley R, et al. The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial. Lancet. 2017;390(10095):649–658.
   PubMed Web of Science ®Google Scholar
• Ita K. Transdermal delivery of vaccines–Recent progress and critical issues. Biomed Pharmacother. 2016;83:1080–1088.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Ukidve A, Dasgupta A, et al. Transdermal immunomodulation: principles, advances and perspectives. Adv Drug Deliv Rev. 2018;127:3–19.
   PubMed Web of Science ®Google Scholar
• Godefroy S, Peyre M, Garcia N, et al. Effect of skin barrier disruption on immune responses to topically applied cross-reacting material, CRM197, of diphtheria toxin. Infect Immun. 2005;73(8):4803–4809.
   PubMed Web of Science ®Google Scholar
• Weber CS, Hainz K, Deressa T, et al. Immune reactions against gene gun vaccines are differentially modulated by distinct dendritic cell subsets in the skin. PloS One. 2015;10(6):e0128722.
   Web of Science ®Google Scholar
• Paudel KS, Milewski M, Swadley CL, et al. Challenges and opportunities in dermal/transdermal delivery. Ther Deliv. 2010;1(1):109–131.
   PubMedGoogle Scholar
• Sklar LR, Burnett CT, Waibel JS, et al. Laser assisted drug delivery: a review of an evolving technology. Lasers Surg Med. 2014;46(4):249–262.
   PubMed Web of Science ®Google Scholar
• Scheiblhofer S, Thalhamer J, Weiss R. Laser microporation of the skin: prospects for painless application of protective and therapeutic vaccines. Expert Opin Drug Deliv. 2013;10(6):761–773.
   PubMed Web of Science ®Google Scholar
• Chen X, Wang J, Shah D, et al. An update on the use of laser technology in skin vaccination. Expert Rev Vaccines. 2013;12(11):1313–1323.
   PubMed Web of Science ®Google Scholar
• Kashiwagi S, Brauns T, Gelfand J, et al. Laser vaccine adjuvants: history, progress, and potential. Human Vaccines Immunother. 2014;10(7):1892–1907.
   PubMed Web of Science ®Google Scholar
• Hong X, Wei L, Wu F, et al. Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine. Drug Design Dev Ther. 2013;7:945.
   PubMed Web of Science ®Google Scholar
• Lee K, Lee CY, Jung H. Dissolving microneedles for transdermal drug administration prepared by stepwise controlled drawing of maltose. Biomaterials. 2011;32(11):3134–3140.
   PubMed Web of Science ®Google Scholar
• Perennes F, Marmiroli B, Matteucci M, et al. Sharp beveled tip hollow microneedle arrays fabricated by LIGA and 3D soft lithography with polyvinyl alcohol. J Micromech Microeng. 2006;16(3):473.
   Web of Science ®Google Scholar
• Prausnitz MR. Engineering microneedle patches for vaccination and drug delivery to skin. Ann Rev Chem Biomol Eng. 2017;8:177–200.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Takahashi T, Aoyagi S. 3D laser lithographic fabrication of hollow microneedle mimicking mosquitos and its characterisation. Int J Nanotechnol. 2018;15(1–3):157–173.
   Web of Science ®Google Scholar
• Cheung K, Han T, Das DB. Effect of force of microneedle insertion on the permeability of insulin in skin. J Diabetes Sci Technol. 2014;8(3):444–452.
   PubMedGoogle Scholar
• Nejad HR, Sadeqi A, Kiaee G, et al. Low-cost and cleanroom-free fabrication of microneedles. Microsyst Nanoeng. 2018;4(1): 1–7.
   PubMed Web of Science ®Google Scholar
• Packianather M, Le C, Pham DT, et al. Advanced micro and nano manufacturing technologies used in medical domain. International Conference on the Development of Biomedical Engineering in Vietnam. Springer, Singapore; 2017.
   Google Scholar
• Sullivan SP, Murthy N, Prausnitz MR. Minimally invasive protein delivery with rapidly dissolving polymer microneedles. Adv Mater. 2008;20(5):933–938.
   PubMed Web of Science ®Google Scholar
• Oun R, Plumb JA, Wheate NJ. A cisplatin slow-release hydrogel drug delivery system based on a formulation of the macrocycle cucurbit [7] uril, gelatin and polyvinyl alcohol. J Inorg Biochem. 2014;134:100–105.
   PubMed Web of Science ®Google Scholar
• Murakami T, Sakai N, Yamaguchi T, et al. Evaluation of a superior lubrication mechanism with biphasic hydrogels for artificial cartilage. Tribol Int. 2015;89:19–26.
   Web of Science ®Google Scholar
• Noh T, Bando Y, Ota K, et al. Tear force of physically crosslinked poly (vinyl alcohol) gels with different submicrometer‐scale network structures. J Appl Polym Sci. 2015;132(4). Doi:10.1002/app.41356.
   Web of Science ®Google Scholar
• Jenkins D, Corrie S, Flaim C, et al. High density and high aspect ratio solid micro-nanoprojection arrays for targeted skin vaccine delivery and specific antibody extraction. Rsc Adv. 2012;2(8):3490–3495.
   Web of Science ®Google Scholar
• Ng H-I, Fernando GJ, Depelsenaire AC, et al. Potent response of QS-21 as a vaccine adjuvant in the skin when delivered with the Nanopatch, resulted in adjuvant dose sparing. Sci Rep. 2016;6:29368.
   PubMed Web of Science ®Google Scholar
• Fernando GJ, Hickling J, Flores CMJ, et al. Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™). Vaccine. 2018;36(26):3779–3788.
   PubMed Web of Science ®Google Scholar
• Johnson AR, Procopio AT. Low cost additive manufacturing of microneedle masters. 3D Print Med. 2019;5(1):2.
   PubMedGoogle Scholar
• Wilke N, Mulcahy A, Ye S-R, et al. Process optimization and characterization of silicon microneedles fabricated by wet etch technology. Microelectronics J. 2005;36(7):650–656.
   Web of Science ®Google Scholar
• Takahashi H, Heo YJ, Arakawa N, et al. Scalable fabrication of microneedle arrays via spatially controlled UV exposure. Microsyst Nanoeng. 2016;2(1):1–9.
   Web of Science ®Google Scholar
• Krieger KJ, Bertollo N, Dangol M, et al. Simple and customizable method for fabrication of high-aspect ratio microneedle molds using low-cost 3D printing. Microsyst Nanoeng. 2019;5(1):1–14.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang H, Yang R, et al. Fabrication of sharp silicon hollow microneedles by deep-reactive ion etching towards minimally invasive diagnostics. Microsyst Nanoeng. 2019;5(1):1–11.
   PubMed Web of Science ®Google Scholar
• Balmert SC, Carey CD, Falo GD, et al. Dissolving undercut microneedle arrays for multicomponent cutaneous vaccination. J Control Release. 2020;317:336–346.
   PubMed Web of Science ®Google Scholar
• Dean CH, Alarcon JB, Waterston AM, et al. Cutaneous delivery of a live, attenuated chimeric flavivirus vaccines against Japanese encephalitis (ChimeriVaxTM-JE) in non-human primates. Human Vaccines. 2005;1(3):106–111.
   PubMed Web of Science ®Google Scholar
• Hirschberg HJ, van de Wijdeven GG, Kraan H, et al. Bioneedles as alternative delivery system for hepatitis B vaccine. J Control Release. 2010;147(2):211–217.
   PubMed Web of Science ®Google Scholar
• Kim Y-C, Quan F-S, Yoo D-G, et al. Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles. J Infect Dis. 2010;201(2):190–198.
   PubMed Web of Science ®Google Scholar
• Sullivan SP, Koutsonanos DG, Del Pilar Martin M, et al. Dissolving polymer microneedle patches for influenza vaccination. Nat Med. 2010;16(8):915.
   PubMed Web of Science ®Google Scholar
• Alarcon JB, Hartley AW, Harvey NG, et al. Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines. Clin Vaccine Immunol. 2007;14(4):375–381.
   PubMed Web of Science ®Google Scholar
• Moon S, Wang Y, Edens C, et al. Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch. Vaccine. 2013;31(34):3396–3402.
   PubMed Web of Science ®Google Scholar
• Weldon WC, Martin MP, Zarnitsyn V, et al. Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity. Clin Vaccine Immunol. 2011;18(4):647–654.
   PubMed Web of Science ®Google Scholar
• Fernando GJ, Chen X, Prow TW, et al. Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model. PloS One. 2010;5(4):e10266.
   PubMed Web of Science ®Google Scholar
• Raphael AP, Prow TW, Crichton ML, et al. Targeted, needle‐free vaccinations in skin using multilayered, densely‐packed dissolving microprojection arrays. Small. 2010;6(16):1785–1793.
   PubMed Web of Science ®Google Scholar
• Chen X, Corbett HJ, Yukiko SR, et al. Site‐selectively coated, densely‐packed microprojection array patches for targeted delivery of vaccines to skin. Adv Funct Mater. 2011;21(3):464–473.
   Web of Science ®Google Scholar
• Koutsonanos DG, Vassilieva EV, Stavropoulou A, et al. Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection. Sci Rep. 2012;2:357.
   PubMed Web of Science ®Google Scholar
• Corbett HJ, Fernando GJ, Chen X, et al. Skin vaccination against cervical cancer associated human papillomavirus with a novel micro-projection array in a mouse model. PloS One. 2010;5(10):e13460.
   PubMed Web of Science ®Google Scholar
• Song J-M, Kim Y-C, Lipatov AS, et al. Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B-and T-cell responses in mice. Clin Vaccine Immunol. 2010;17(9):1381–1389.
   PubMedGoogle Scholar
• Song J-M, Kim Y-C, Barlow PG, et al. Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles. Antiviral Res. 2010;88(2):244–247.
   PubMed Web of Science ®Google Scholar
• Pearton M, Kang S-M, Song J-M, et al. Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin. Vaccine. 2010;28(37):6104–6113.
   PubMed Web of Science ®Google Scholar
• Mikszta JA, Dekker JP, Harvey NG, et al. Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine. Infect Immun. 2006;74(12):6806–6810.
   PubMed Web of Science ®Google Scholar
• Wendorf JR, Ghartey-Tagoe EB, Williams SC, et al. Transdermal delivery of macromolecules using solid-state biodegradable microstructures. Pharm Res. 2011;28(1):22–30.
   PubMed Web of Science ®Google Scholar
• Ding Z, Van Riet E, Romeijn S, et al. Immune modulation by adjuvants combined with diphtheria toxoid administered topically in BALB/c mice after microneedle array pretreatment. Pharm Res. 2009;26(7):1635–1643.
   PubMed Web of Science ®Google Scholar
• Bal SM, Ding Z, Kersten GF, et al. Microneedle-based transcutaneous immunisation in mice with N-trimethyl chitosan adjuvanted diphtheria toxoid formulations. Pharm Res. 2010;27(9):1837–1847.
   PubMed Web of Science ®Google Scholar
• Hirschberg HJ, van de Wijdeven GG, Kelder AB, et al. Bioneedles™ as vaccine carriers. Vaccine. 2008;26(19):2389–2397.
   PubMed Web of Science ®Google Scholar
• Hiraishi Y, Nandakumar S, Choi S-O, et al. Bacillus Calmette-Guerin vaccination using a microneedle patch. Vaccine. 2011;29(14):2626–2636.
   PubMed Web of Science ®Google Scholar
• Morefield GL, Tammariello RF, Purcell BK, et al. An alternative approach to combination vaccines: intradermal administration of isolated components for control of anthrax, botulism, plague and staphylococcal toxic shock. J Immune Based Ther Vaccines. 2008;6(1):5.
   PubMedGoogle Scholar
• Prow TW, Chen X, Prow NA, et al. Nanopatch‐targeted skin vaccination against West Nile virus and chikungunya virus in mice. Small. 2010;6(16):1776–1784.
   PubMed Web of Science ®Google Scholar
• Gill HS, Söderholm J, Prausnitz MR, et al. Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine. Gene Ther. 2010;17(6):811–814.
   PubMed Web of Science ®Google Scholar
• Mikszta JA, Alarcon JB, Brittingham JM, et al. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat Med. 2002;8(4):415–419.
   PubMed Web of Science ®Google Scholar
• Kask AS, Chen X, Marshak JO, et al. DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge. Vaccine. 2010;28(47):7483–7491.
   PubMed Web of Science ®Google Scholar
• DeMuth PC, Min Y, Huang B, et al. Polymer multilayer tattooing for enhanced DNA vaccination. Nat Mater. 2013;12(4):367–376.
   PubMed Web of Science ®Google Scholar
• Forster AH, Witham K, Depelsenaire AC, et al. Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: results from a randomized, controlled phase I clinical trial. PLoS Med. 2020;17(3): e1003024.
   PubMed Web of Science ®Google Scholar
• Leroux-Roels I, Vets E, Freese R, et al. Seasonal influenza vaccine delivered by intradermal microinjection: a randomised controlled safety and immunogenicity trial in adults. Vaccine. 2008;26(51):6614–6619.
   PubMed Web of Science ®Google Scholar
• Beran J, Ambrozaitis A, Laiskonis A, et al. Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Med. 2009;7(1):13.
   PubMed Web of Science ®Google Scholar
• Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, et al. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine. 2009;27(3):454–459.
   PubMed Web of Science ®Google Scholar
• Troy SB, Kouiavskaia D, Siik J, et al. Comparison of the immunogenicity of various booster doses of inactivated polio vaccine delivered intradermally versus intramuscularly to HIV-infected adults. J Infect Dis. 2015;211(12):1969–1976.
   PubMed Web of Science ®Google Scholar
• Bragazzi NL, Orsi A, Ansaldi F, et al. Fluzone® intra-dermal (Intanza®/Istivac® Intra-dermal): an updated overview. Human Vaccines Immunother. 2016;12(10):2616–2627.
   PubMed Web of Science ®Google Scholar
• Donnelly RF, Singh TRR, Garland MJ, et al. Hydrogel‐forming microneedle arrays for enhanced transdermal drug delivery. Adv Funct Mater. 2012;22(23):4879–4890.
   PubMed Web of Science ®Google Scholar
• Nguyen TT, Oh Y, Kim Y, et al. Progress in microneedle array patch (MAP) for vaccine delivery. Human Vaccines Immunother. 2020;1–12. Doi:10.1080/21645515.2020.1767997.
   PubMed Web of Science ®Google Scholar
• Fogel DB. Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review. Contemp Clin Trials Commun. 2018;11:156–164.
   PubMed Web of Science ®Google Scholar
• Corr P, Williams D. The pathway from idea to regulatory approval: examples for drug development. Nat Acad. 2009.
   Google Scholar
• Wong CH, Siah KW, Lo AW. Estimation of clinical trial success rates and related parameters. Biostatistics. 2019;20(2):273–286.
   PubMed Web of Science ®Google Scholar
• Savitz LA, Savitz ST. Can delivery systems use cost-effectiveness analysis to reduce healthcare costs and improve value? F1000Res. 2016;5:2575.
   PubMedGoogle Scholar
• Adhikari BB, Goodson JL, Chu SY, et al. Assessing the potential cost-effectiveness of microneedle patches in childhood measles vaccination programs: the case for further research and development. Drugs. 2016;16(4):327–338.
   Web of Science ®Google Scholar
• Lee BY, Bartsch SM, Mvundura M, et al. An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine. Vaccine. 2015;33(37):4727–4736.
   PubMed Web of Science ®Google Scholar